Unique ID issued by UMIN | UMIN000026378 |
---|---|
Receipt number | R000030273 |
Scientific Title | Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias |
Date of disclosure of the study information | 2017/03/03 |
Last modified on | 2018/05/09 16:52:40 |
Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias
Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias
Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias
Clinical study of transplacental anti-arrythmic treatment for fetal tachyarrythmias
Japan |
Fetal tachyarrythmia (Supraventricular tachycardia, Atrial flutter)
Cardiology | Obstetrics and Gynecology | Pediatrics |
Others
NO
To estimate the efficacy and safety of transplacental anti-arrythmic treatment for fetal tachyarrythmias
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
disappearance of fetal tachyarrythmias in more than half of 30min fetal echocardiogram and/or 40min cardiotocogram
1 Intrauterine Fetal Death
2 Rate of preterm birth
3 Rate of cesarean section
4 Improvement of fetal heart rate and/or fetal hydrops
5 Neonatal arrythmias
6 CNS findings in neonate
7 Survival rate at 1 month
8 Tachyarrythmias at 1 month
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
These anti-arrythmic agent are administered to pregnant women as treatment for fetal supraventricular tachycardia with short VA interval or atrial flutter. Administration is started with 2nd for fetal hydrops. If the administration of digoxin is ineffective, digoxin is possible to be discontinued.
1st. digoxin
2nd. digoxin and sotalol
3rd. digoxin and flecainide
These anti-arrythmic agent are administered to pregnant women as treatment for fetal supraventricular tachycardia with long VA interval.
1st. sotalol
2nd. flecainide
Not applicable |
Not applicable |
Male and Female
1 sustained fetal tachyarrythmias
2 gestational age 22w0d~36w6d
3 singleton
4 Informed consent has been obtained from patient
1 it is impossible to obtain informed consent due to the mental problem
2 the treatment causes serious risk for mother's health
3 Doctor judged inappropriate for the treatment
5
1st name | |
Middle name | |
Last name | Maki Inoue |
Gunma University Hospital
Department of Obstetrics and Gynecology
Maebashi, Gunma
+81-27-220-8429
m-inoue@gunma-u.ac.jp
1st name | |
Middle name | |
Last name | Maki Inoue |
Gunma University Hospital
Department of Obstetrics and Gynecology
Maebashi, Gunma
+81-27-220-8429
m-inoue@gunma-u.ac.jp
Gunma University Hospital
Gunma University Hospital
Self funding
NO
群馬大学医学部附属病院
2017 | Year | 03 | Month | 03 | Day |
Unpublished
Terminated
2017 | Year | 02 | Month | 22 | Day |
2017 | Year | 03 | Month | 01 | Day |
2017 | Year | 03 | Month | 03 | Day |
2018 | Year | 05 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030273
Research Plan | |
---|---|
Registered date | File name |
2018/05/07 | 胎児不整脈 介入研究実施作成指針3 2017年4月.doc |
Research case data specifications | |
---|---|
Registered date | File name |
2018/05/09 | 胎児頻脈性不整脈 新生児CRF.xls |
Research case data | |
---|---|
Registered date | File name |
2018/05/09 | 胎児頻脈性不整脈 新生児CRF.xls |
Value
https://center6.umin.ac.jp/ice/30273